AAAAAA
Results: 1-25/29
Authors:
VASSAL G
BOLAND I
TERRIERLACOMBE MJ
WATSON AJ
MARGISON GP
VENUAT AM
MORIZET J
PARKER F
LACROIX C
LELLOUCHTUBIANA A
PIERREKAHN A
POULLAIN MG
GOUYETTE A
Citation: G. Vassal et al., ACTIVITY OF FOTEMUSTINE IN MEDULLOBLASTOMA AND MALIGNANT GLIOMA XENOGRAFTS IN RELATION TO O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND ALKYLPURINE-DNA N-GLYCOSYLASE ACTIVITY, Clinical cancer research, 4(2), 1998, pp. 463-468
Authors:
VASSAL G
BOLAND I
TERRIERLACOMBE MJ
WATSON AJ
MARGISON GP
VENUAT AM
MORIZET J
PARKER F
LACROIX C
LELLOUCHTUBIANA A
PIERREKAHN A
POULLAIN MG
GOUYETTE A
Citation: G. Vassal et al., ACTIVITY OF FOTEMUSTINE IN MEDULLOBLASTOMA AND MALIGNANT GLIOMA XENOGRAFTS IN RELATION TO O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND ALKYLPURINE-DNA N-GLYCOSYLASE ACTIVITY, Clinical cancer research, 4(2), 1998, pp. 463-468
Authors:
BOIGE V
RAYMOND E
FABBRO M
PLAZZA J
VASSAL G
RISSE ML
RODIER JM
ARMAND JP
Citation: V. Boige et al., PHASE-II TRIAL AND PHARMACOKINETIC STUDY OF IRINOTECAN (CPT-11) IN PATIENTS WITH GLIOBLASTOMA, Annals of oncology, 9, 1998, pp. 657-657
Authors:
SALIBA F
HAGIPANTELLI R
MISSET JL
BASTIAN G
VASSAL G
BONNAY M
HERAIT P
COTE C
MAHJOUBI M
MIGNARD D
CVITKOVIC E
Citation: F. Saliba et al., PATHOPHYSIOLOGY AND THERAPY OF IRINOTECAN-INDUCED DELAYED-ONSET DIARRHEA IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - A PROSPECTIVE ASSESSMENT, Journal of clinical oncology, 16(8), 1998, pp. 2745-2751
Authors:
SMITH M
BERNSTEIN M
BLEYER WA
BORSI JD
HO P
LEWIS IJ
PEARSON A
PEIN F
PRATT C
REAMAN G
RICCARDI R
SEIBEL N
TRUEWORTHY R
UNGERLEIDER R
VASSAL G
VIETTI T
Citation: M. Smith et al., CONDUCT OF PHASE-I TRIALS IN CHILDREN WITH CANCER, Journal of clinical oncology, 16(3), 1998, pp. 966-978
Authors:
VASSAL G
PONDARRE C
BOLAND I
CAPPELLI C
SANTOS A
THOMAS C
LUCCHI E
IMADALOU K
PEIN F
MORIZET J
GOUYETTE A
Citation: G. Vassal et al., PRECLINICAL DEVELOPMENT OF CAMPTOTHECIN DERIVATIVES AND CLINICAL-TRIALS IN PEDIATRIC ONCOLOGY, Biochimie, 80(3), 1998, pp. 271-280
Authors:
LEVU B
DEVATHAIRE F
SHAMSALDIN A
HAWKINS MM
GRIMAUD E
HARDIMAN C
DIALLO I
VASSAL G
BESSA E
CAMPBELL S
PANIS X
DALYSCHVEITZER N
LAGRANGE JL
ZUCKER JM
ESCHWEGE F
CHAVAUDRA J
LEMERLE J
Citation: B. Levu et al., RADIATION-DOSE, CHEMOTHERAPY AND RISK OF OSTEOSARCOMA AFTER SOLID TUMORS DURING CHILDHOOD, International journal of cancer, 77(3), 1998, pp. 370-377
Authors:
PEIN F
DOZ F
FRAPPAZ D
LUCCHI E
MORETTI S
SANTOS D
MIGNARD D
VASSAL G
Citation: F. Pein et al., PHASE-I TRIAL OF IRINOTECAN (CPT-11)I IN CHILDHOOD SOLID TUMORS, European journal of cancer, 33, 1997, pp. 1126-1126
Authors:
VASSAL G
PONDARRE C
CAPPELLI C
TERRIERLACOMBE MJ
BOLAND I
MORIZET J
BENARD J
VENUAT AM
ARDOUIN P
HARTMANN O
GOUYETTE A
Citation: G. Vassal et al., DNA-TOPOISOMERASE-I, A NEW TARGET FOR THE TREATMENT OF NEUROBLASTOMA, European journal of cancer, 33(12), 1997, pp. 2011-2015
Authors:
HARTMANN O
VALTEAUCOUANET D
BENHAMOU E
VASSAL G
RUBIE H
BEAUJEAN F
LEMERLE J
Citation: O. Hartmann et al., STAGE-IV NEUROBLASTOMA IN PATIENTS OVER 1 YEAR OF AGE AT DIAGNOSIS - CONSOLIDATION OF POOR RESPONDERS WITH COMBINED BUSULFAN, CYCLOPHOSPHAMIDE AND MELPHALAN FOLLOWED BY IN-VITRO MAFOSFAMIDE-PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION, European journal of cancer, 33(12), 1997, pp. 2126-2129
Authors:
VASSAL G
BOLAND I
SANTOS A
BISSERY MC
TERRIERLACOMBE MJ
MORIZET J
SAINTEROSE C
LELLOUCHTUBIANA A
KALIFA C
GOUYETTE A
Citation: G. Vassal et al., POTENT THERAPEUTIC ACTIVITY OF IRINOTECAN (CPT-11) AND ITS SCHEDULE DEPENDENCY IN MEDULLOBLASTOMA XENOGRAFTS IN NUDE-MICE, International journal of cancer, 73(1), 1997, pp. 156-163
Authors:
RAMIREZ LH
ZHAO ZX
ROUGIER P
BOGNEL C
DZODIC R
VASSAL G
ARDOUIN P
GOUYETTE A
MUNCK JN
Citation: Lh. Ramirez et al., PHARMACOKINETICS AND ANTITUMOR EFFECTS OF MITOXANTRONE AFTER INTRATUMORAL OR INTRAARTERIAL HEPATIC ADMINISTRATION IN RABBITS, Cancer chemotherapy and pharmacology, 37(4), 1996, pp. 371-376
Authors:
VASSAL G
KOSCIELNY S
CHALLINE D
VALTEAUCOUANET D
BOLAND I
DEROUSSENT A
LEMERLE J
GOUYETTE A
HARTMANN O
Citation: G. Vassal et al., BUSULFAN DISPOSITION AND HEPATIC VENOOCCLUSIVE DISEASE IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION, Cancer chemotherapy and pharmacology, 37(3), 1996, pp. 247-253
Authors:
GRILL J
LEDELEY MC
VALTEAUCOUANET D
VASSAL G
BONNAY M
BENHAMOU E
HARTMANN O
Citation: J. Grill et al., PREVIOUS CONVENTIONAL CHEMOTHERAPY IS THE PRINCIPAL RISK FACTOR FOR IMMUNOGLOBULIN DEFICIENCY DURING THE EARLY POST-ABMT PERIOD IN CHILDREN, Bone marrow transplantation, 18(2), 1996, pp. 325-332
Authors:
VALTEAUCOUANET D
VASSAL G
PONDARRE C
BONNAY M
BENHAMOU E
COUANET D
PLANTAZ D
HARTMANN O
Citation: D. Valteaucouanet et al., PHASE-I STUDY OF HIGH-DOSE CONTINUOUS INTRAVENOUS-INFUSION OF VP-16 IN COMBINATION WITH HIGH-DOSE MELPHALAN FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHILDREN WITH STAGE-IV NEUROBLASTOMA, Bone marrow transplantation, 17(4), 1996, pp. 485-489
Authors:
VASSAL G
TERRIERLACOMBE MJ
LELLOUCHTUBIANA A
VALERY CA
SAINTEROSE C
MORIZET J
ARDOUIN P
RIOU G
KALIFA C
GOUYETTE A
Citation: G. Vassal et al., TUMORIGENICITY OF CEREBELLAR PRIMITIVE NEURO-ECTODERMAL TUMORS IN ATHYMIC MICE CORRELATES WITH POOR-PROGNOSIS IN CHILDREN, International journal of cancer, 69(2), 1996, pp. 146-151
Authors:
VASSAL G
TERRIERLACOMBE MJ
BISSERY MC
VENUAT AM
GYERGYAY F
BENARD J
MORIZET J
BOLAND I
ARDOUIN P
BRESSACDEPAILLERETS B
GOUYETTE A
Citation: G. Vassal et al., THERAPEUTIC ACTIVITY OF CPT-11, A DNA-TOPOISOMERASE-I INHIBITOR, AGAINST PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR AND NEUROBLASTOMA XENOGRAFTS, British Journal of Cancer, 74(4), 1996, pp. 537-545
Authors:
DANGLOT G
REGNIER V
FAUVET D
VASSAL G
KUJAS M
BERNHEIM A
Citation: G. Danglot et al., NEUROFIBROMATOSIS-1 (NF1) MESSENGER-RNAS EXPRESSED IN THE CENTRAL-NERVOUS-SYSTEM ARE DIFFERENTIALLY SPLICED IN THE 5' PART OF THE GENE, Human molecular genetics, 4(5), 1995, pp. 915-920
Authors:
LECESNE A
VASSAL G
FARACE F
SPIELMANN M
LECHEVALIER T
TURSZ T
ESCUDIER B
Citation: A. Lecesne et al., CONCOMITANT INTERLEUKIN-2-DOXORUBICIN (ADR) SCHEDULE IN PATIENTS (PTS) WITH ADVANCED SOFT-TISSUE SARCOMAS (ASTS) - A PHARMACOKINETIC STUDY, European journal of cancer, 31A, 1995, pp. 586-586
Authors:
MISSET JL
SALIBA F
GIACCHETTI S
BRAIN E
VASSAL G
BONNAY M
BASTIAN G
COTE C
MAHJOUBI M
HERAIT P
HAGIPANTELLI R
CVITKOVIC E
Citation: Jl. Misset et al., PATHOPHYSIOLOGY AND THERAPY OF IRINOTECAN (CPT-11) INDUCED DELAYED-ONSET DIARRHEA (DD) - A PROSPECTIVE ASSESSMENT, European journal of cancer, 31A, 1995, pp. 742-742
Authors:
PEIN F
VASSAL G
SAKIROGLU C
TOURNADE MF
LEMERLE J
Citation: F. Pein et al., PEDIATRIC FEATURES OF ANTHRACYCLINES CARD IAC TOXICITY AND PRACTICAL IMPLICATIONS FOR PREVENTION, Archives de pediatrie, 2(10), 1995, pp. 988-999
Authors:
VASSAL G
PEIN F
Citation: G. Vassal et F. Pein, LONG-TERM RISK-FACTORS OF ANTICANCER MEDI CATION FOR CHILDREN, Archives de pediatrie, 2, 1995, pp. 104-105
Authors:
CANIONI D
VASSAL G
DONADIEU J
HUBERT P
BROUSSE N
Citation: D. Canioni et al., TOXICITY INDUCED BY CHEMOTHERAPY MIMICKING CYTOMEGALOVIRUS GASTRITIS, Histopathology, 26(5), 1995, pp. 473-475
Authors:
AUTRET E
VASMANT D
BEGAUD B
DUPORTAL HD
BOUTROY MJ
CEZARD JP
DELBOS L
ESCHWEGE E
GOUJARD J
ICHOU F
JACQZAIGRAIN E
KOUZAN S
LASSALE C
LEROY B
OSTINELLI J
PLETAN Y
PONS G
SAUVANET JP
SINGLAS E
TABURET AM
THERENEFENOGLIO MC
TILLEMENT JP
VASSAL G
SAINTSALVY B
Citation: E. Autret et al., DETERMINATION OF DRUG-DOSAGE IN PEDIATRIC S, Therapie, 50(4), 1995, pp. 381-386
Authors:
VASSAL G
Citation: G. Vassal, PHARMACOLOGICALLY-GUIDED DOSE ADJUSTMENT OF BUSULFAN IN HIGH-DOSE CHEMOTHERAPY REGIMENS - RATIONALE AND PITFALLS, Anticancer research, 14(6A), 1994, pp. 2363-2370